Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022716 (
Menkes
)
1,057
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Numerous control systems are involved in the growth and differentiation of chondro-osseous tissue. Theoretically, the failure of each single step will result in a peculiar skeletal dysplasia. The resulting disorders are caused by errors in the metabolism of collagen, minerals, complex carbohydrates and the protein of the ground substance. Skeletal dysplasias with a known or probable metabolic base include osteogenesis imperfecta, osteoectasia with macrocranium,
Menkes syndrome
, the mucopolysaccharidoses and hypophosphatasia.
...
PMID:[The metabolic basis of generalized skeletal dysplasia (author's transl)]. 82 73
The gene responsible for
Menkes syndrome
has been assigned to Xq13 by a combination of comparative mapping and linkage analysis. A previous report has mapped the translocation breakpoint associated with the disease in a female patient to an interval delimited by PGK1 and a group of six more proximal Xq13 markers, including DXS56. We have characterized a number of PGK1- or DXS56-positive YACs, from which we have generated six new markers. One of them identifies a small overlap region between a PGK1-positive YAC and three DXS56-positive YACs, distal to the
Menkes
breakpoint. A 560-kb region covered by a DXS56-positive YAC has been restriction-mapped and subcloned, disclosing a 187-kb MluI fragment astride the breakpoint. A probe mapping distal to the rearrangement in the same interval reveals altered PGFE fragments in a hybrid constructed from the translocation patient's DNA. We describe the development of a cosmid contig extending 150 kb from a nearby CpG island across the breakpoint. This contig includes four adjacent clones displaying cross-specific hybridization.
...
PMID:Fine mapping and cloning of the breakpoint associated with Menkes syndrome in a female patient. 142 84
Increasing loss of vision caused by peculiar macroscopic and functional retinal changes was the first ophthalmologic manifestation of Wilson's disease in a 22-year-old patient. Neither retinal changes nor great visual impairment has been described thus far in the literature concerning this disease. Likely correlations are discussed with
Menkes syndrome
, an X-linked inborn error of copper metabolism with onset in early childhood.
...
PMID:[Retinal changes in Wilson's disease]. 188 68
Menkes syndrome
is a rare X-linked recessive disorder characterized by an inability to metabolize copper. A female patient with both this disease and an X; autosome translocation with karyotype 46,X,t(X;2)(q13;q32.2) has previously been described. The translocation breakpoint in Xq13 coincides with a previous assignment of the
Menkes
gene at Xq13 by linkage data in humans and by analogy to the mottled mutations which are models for
Menkes disease
in the mouse. Therefore, this translocation probably interrupts the gene for
Menkes syndrome
in band Xq13. We describe here experiments to precisely map the translocation breakpoint within this chromosomal band. We have established a lymphoblastoid cell line from this patient and have used it to isolate the der(2) translocation chromosome (2pter----2q32::Xq13----Xqter) in human/hamster somatic cell hybrids. Southern blot analyses using a number of probes specific for chromosomes X and 2 have been studied to define precisely the location of the translocation breakpoint. Our results show that the breakpoint in this patient--and, therefore, likely the
Menkes
gene--maps to a small subregion of band Xq13.2-q13.3 proximal to the PGK1 locus and distal to all other Xq13 loci tested.
...
PMID:Localization of the translocation breakpoint in a female with Menkes syndrome to Xq13.2-q13.3 proximal to PGK-1. 203 33
Three female patients with
Menkes syndrome
are described. Clinically, they have typical
Menkes syndrome
. Biochemically, they have significantly increased 64Cu-uptake in cultured fibroblasts. The chromosomal analysis was normal for two of the patients and abnormal for one patient (45X/46XX mosaicism).
...
PMID:Clinical expression of Menkes syndrome in females. 228 18
The mitochondrial copper concentrations and cytochrome C oxidase activity of the fibroblasts from the patients with
Menkes syndrome
were investigated. Both the mitochondrial copper concentrations and cytochrome C oxidase activity of fibroblasts from patients with
Menkes syndrome
were lower than those of the control fibroblasts. These data indicate that the mitochondria of fibroblasts from patients with
Menkes syndrome
are in a state of copper deficiency. The activity decline of cytochrome C oxidase, a mitochondrial cuproenzyme, seems to be caused by copper deficiency in the mitochondria.
...
PMID:Copper deficiency in the mitochondria of cultured skin fibroblasts from patients with Menkes syndrome. 256 98
A 3 2/12-year-old boy had recurrent seizures, chronic respiratory infection, and delayed physical and mental development. He also had low plasma copper content typical of
Menkes syndrome
. Autopsy showed marked neuronal loss and gliosis in most areas of the cerebral and cerebellar cortices, midbrain, pons, and medulla. The spinal cord showed severe demyelination in both ascending (spinocerebellar) and descending (lateral corticospinal) tracts from the cervical to the sacral level. In addition to these neuronal lesions, both the meningeal and parenchymal arterial and venous branches were remarkably dilated in the brain and spinal cord. Our previous study of this case showed abnormal perivascular innervation and abnormal axonal swelling of the postganglionic adrenergic fibers elsewhere in the body. The metabolic disorder caused by copper deficiency induces severe neuronal degeneration that is apparently exaggerated by extensive and progressive vascular abnormality.
...
PMID:Neuronal and vascular disorders of the brain and spinal cord in Menkes kinky hair disease. 313 Aug 71
Six patients with
Menkes syndrome
are described, who differ from patients with the classical form of
Menkes syndrome
because of their longer survival; some of them also exhibited a milder manifestation of symptoms. Based on the present data and a summary of seven case reports describing
Menkes
patients with long survival, it may be possible to divide these patients into two subgroups: one group of severely affected patients with long survival and another group of very mildly affected patients with late onset of symptoms. Perhaps only the latter represents a true subgroup of
Menkes syndrome
. The possible benefits of copper therapy are discussed.
...
PMID:Variability in clinical expression of Menkes syndrome. 323 33
The life-span of
Menkes syndrome
patients is discussed in connection with a boy suffering from this disease who lived to the age of 13.5 years. The copper metabolism defect is described. Therapeutic trials, mainly copper substitution, and prospects are summed up.
...
PMID:Life-span and Menkes kinky hair syndrome: report of a 13-year course of this disease. 335 80
We report on a girl with
Menkes syndrome
(M.S.) and X-2 reciprocal translocation. We conclude that the probable locus for M.S. gene is at band Xq13. This case and other previous case reports of X-linked disorders in females suggest that chromosome analysis is indicated in all females who present with manifestations of a known X-linked lethal condition in order to detect a possible associated balanced X-autosome translocation.
...
PMID:Menkes syndrome in a girl with X-autosome translocation. 381
1
2
3
4
5
6
7
Next >>